HR 2815 · 117th Congress 2021โ€“2023, ended

BIOSIM Act

Latest action · Apr 23, 2021 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 22, 2021
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act

This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.

Cosponsors 4

Members who signed on, in the order they did. Signatures ran from Apr 22, 2021 to Jul 22, 2021; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-ILAdam KinzingerOriginalApr 22, 2021
D-NCG. K. ButterfieldJun 29, 2021
D-NJMikie SherrillJun 29, 2021
D-WAKim SchrierJul 22, 2021

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 22, 2021
Health Subcommittee
Referred Apr 23, 2021
HouseWays and Means Committee
Referred Apr 22, 2021
Health Subcommittee
Referred Apr 22, 2021
Social Security Subcommittee
Referred Apr 22, 2021

Actions 5

Everything that happened, newest first.

  1. Apr 23, 2021Referred to the Subcommittee on Health.
  2. Apr 22, 2021Introduced in House
  3. Apr 22, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Apr 22, 2021Referred to the Subcommittee on Health.
  5. Apr 22, 2021Referred to the Subcommittee on Social Security.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, clause 3.

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 70, April 22, 2021, page H2109.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 117-809PRESCRIPTION DRUG PRICE INFLATION: AN URGENT NEED TO LOWER DRUG PRICES IN MEDICARE224 pagesFinance CommitteeMar 16, 2022
Serial No. 117-27NEGOTIATING A BETTER DEAL: LEGISLATION TO LOWER THE COST OF PRESCRIPTION DRUGS139 pagesEnergy and Commerce CommitteeMay 4, 2021

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 4455BIOSIM ActReintroduction ofSep 23, 2019
HR 5376An act to provide for reconciliation pursuant to title II of S. Con. Res. 14.Related billAug 16, 2022
HR 7497Make Medicine Affordable ActRelated billApr 12, 2022

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.
Short Title(s) as Introduced
BIOSIM Act
Bolstering Innovative Options to Save Immediately on Medicines Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 22, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.